인간 간 모델 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 제품별(2D 모델, 3D 바이오프린팅, 간 오가노이드), 용도별(Drug Discovery, 학술 및 조사), 지역별, 경쟁별(2020-2030F)
Human Liver Model Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (2D Models, 3D Bio Printing, Liver Organoids), By Application (Drug Discovery, Academics & Research), By Region & Competition, 2020-2030F
상품코드:1698183
리서치사:TechSci Research
발행일:2025년 03월
페이지 정보:영문 185 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 인간 간 모델 시장 규모는 2024년에 6억 1,595만 달러에 달하며, 예측 기간의 CAGR은 4.12%로 2030년까지 안정된 성장이 예측됩니다.
세계 인간 간 모델 시장은 생명공학의 획기적인 발전, 간 질환 유병률 증가, 보다 정밀한 약물 검사 플랫폼에 대한 수요 증가로 인해 빠르게 성장하고 있습니다. 대사성 질환, 바이러스성 간염, 알코올 관련 간 질환이 급증함에 따라 제약 및 생명공학 기업은 신약 개발, 독성 스크리닝, 재생의학 연구를 강화하기 위해 첨단 간 모델에 많은 투자를 하고 있습니다.
시장 개요
예측 기간
2026-2030
시장 규모 : 2024년
6억 1,595만 달러
시장 규모 : 2030년
7억 8,663만 달러
CAGR : 2025-2030년
4.12%
급성장 부문
2D 모델
최대 시장
북미
간암의 발병률과 사망률이 증가함에 따라 보다 효과적이고 예측 가능한 연구 모델에 대한 긴급한 요구가 증가하고 있습니다. 또한 간 이식을 위한 기증 장기의 부족으로 인해 바이오 엔지니어링 간 조직 및 대체 치료 솔루션의 개발이 가속화되고 있으며, 이 분야의 기술 혁신이 더욱 가속화되고 있습니다.
주요 시장 성장 촉진요인
의약품 연구의 진보
주요 시장이 해결해야 할 과제
간기능의 복잡성
주요 시장 동향
Multi-Organ-on-a-Chip 시스템
목차
제1장 개요
제2장 조사 방법
제3장 개요
제4장 고객의 소리
제5장 세계의 인간 간 모델 시장 전망
시장 규모·예측
금액별
시장 점유율·예측
제품별(2D 모델, 3D 바이오프린트, 간 오가노이드)
용도별(Drug Discovery, 학술·조사)
지역별
기업별(2024)
제품 시장 맵
제품별
용도별
지역별
제6장 북미의 인간 간 모델 시장 전망
시장 규모·예측
시장 점유율·예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 인간 간 모델 시장 전망
시장 규모·예측
시장 점유율·예측
유럽 : 국가별 분석
독일
영국
프랑스
이탈리아
스페인
제8장 아시아태평양의 인간 간 모델 시장 전망
시장 규모·예측
시장 점유율·예측
아시아태평양 : 국가별 분석
중국
일본
인도
호주
한국
제9장 남미의 인간 간 모델 시장 전망
시장 규모·예측
시장 점유율·예측
남미 : 국가별 분석
브라질
아르헨티나
콜롬비아
제10장 중동 및 아프리카의 인간 간 모델 시장 전망
시장 규모·예측
시장 점유율·예측
중동 및 아프리카 : 국가별 분석
남아프리카공화국
사우디아라비아
아랍에미리트
쿠웨이트
제11장 시장 역학
촉진요인
과제
제12장 시장 동향과 발전
최근 동향
합병과 인수
제품 출시
제13장 Porter's Five Forces 분석
업계내 경쟁
신규 참여의 가능성
공급업체의 힘
고객의 힘
대체품의 위협
제14장 경쟁 구도
Organovo Holdings Inc
BioIVT LLC
InSphero AG
Emulate Inc
Mimetas BV
CN Bio
Cyfuse Biomedical KK
Hurel Corp
제15장 전략적 제안
제16장 조사회사 소개·면책사항
KSA
영문 목차
영문목차
Global Human Liver Model Market was valued at USD 615.95 Million in 2024 and is anticipated to project steady growth in the forecast period with a CAGR of 4.12% through 2030. The Global Human Liver Model Market is expanding rapidly, driven by breakthroughs in bioengineering, rising liver disease prevalence, and the growing need for more precise drug testing platforms. As metabolic disorders, viral hepatitis, and alcohol-related liver conditions continue to surge, pharmaceutical and biotechnology companies are making significant investments in advanced liver models to enhance drug discovery, toxicity screening, and regenerative medicine research.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 615.95 Million
Market Size 2030
USD 786.63 Million
CAGR 2025-2030
4.12%
Fastest Growing Segment
2D Models
Largest Market
North America
The increasing incidence of liver cancer, coupled with high mortality rates, underscores the urgent need for more effective and predictive research models. Additionally, the shortage of donor organs for liver transplants has accelerated the development of bioengineered liver tissues and alternative therapeutic solutions, driving further innovation in the field.
Key Market Drivers
Pharmaceutical Research Advancements
The Global Human Liver Model Market is experiencing a transformative surge in demand, driven in large part by the rapid advancements in pharmaceutical research. As the pharmaceutical industry faces increasing pressure to develop safer and more effective drugs while reducing time and costs, human liver models have emerged as indispensable tools.
Pharmaceutical companies are continually searching for more efficient and accurate ways to evaluate drug candidates. Human liver models provide a realistic and dynamic environment to test potential drugs, predict their pharmacokinetics, and assess their toxicity. This level of precision significantly reduces the risk of late-stage clinical trial failures, leading to substantial cost savings and a more streamlined drug development process.
Key Market Challenges
Complexity of Liver Functionality
The liver is an incredibly complex organ with numerous functions, including detoxification, metabolism, and protein synthesis. Replicating all of its functions accurately in a model is challenging. Researchers are working on improving the physiological relevance of liver models, but achieving a complete emulation remains a formidable task.
Key Market Trends
Multi-Organ-on-a-Chip Systems
The development of multi-organ-on-a-chip systems is a groundbreaking trend. These platforms enable the study of interactions between the liver and other organs, providing a more comprehensive understanding of how drugs and diseases affect the entire human body. Such models hold immense promise for advancing drug development and personalized medicine.
Key Market Players
Organovo Holdings Inc
BioIVT LLC
InSphero AG
Emulate Inc
Mimetas BV
CN Bio
Cyfuse Biomedical KK
Hurel Corp
Report Scope:
In this report, the Global Human Liver Model Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Human Liver Model Market, By Product:
2D Models
3D Bio Printing
Liver Organoids
Human Liver Model Market, By Application:
Drug Discovery
Academics & Research
Human Liver Model Market, By Region:
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Asia-Pacific
China
Japan
India
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Human Liver Model Market.
Available Customizations:
Global Human Liver Model market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Human Liver Model Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (2D Models, 3D Bio Printing, Liver Organoids)
5.2.2. By Application (Drug Discovery, Academics & Research)
5.2.3. By Region
5.2.4. By Company (2024)
5.3. Product Market Map
5.3.1. By Product
5.3.2. By Application
5.3.3. By Region
6. North America Human Liver Model Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (2D Models, 3D Bio Printing, Liver Organoids)
6.2.2. By Application (Drug Discovery, Academics & Research)
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Human Liver Model Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Application
6.3.2. Canada Human Liver Model Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Application
6.3.3. Mexico Human Liver Model Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Application
7. Europe Human Liver Model Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product (2D Models, 3D Bio Printing, Liver Organoids)
7.2.2. By Application (Drug Discovery, Academics & Research)
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Human Liver Model Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Application
7.3.2. United Kingdom Human Liver Model Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Application
7.3.3. France Human Liver Model Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Application
7.3.4. Italy Human Liver Model Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Application
7.3.5. Spain Human Liver Model Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Application
8. Asia-Pacific Human Liver Model Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product (2D Models, 3D Bio Printing, Liver Organoids)
8.2.2. By Application (Drug Discovery, Academics & Research)
8.2.3. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Human Liver Model Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Application
8.3.2. Japan Human Liver Model Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Application
8.3.3. India Human Liver Model Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Application
8.3.4. Australia Human Liver Model Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Application
8.3.5. South Korea Human Liver Model Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Application
9. South America Human Liver Model Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product (2D Models, 3D Bio Printing, Liver Organoids)
9.2.2. By Application (Drug Discovery, Academics & Research)
9.2.3. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Human Liver Model Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Application
9.3.2. Argentina Human Liver Model Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Application
9.3.3. Colombia Human Liver Model Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Application
10. Middle East and Africa Human Liver Model Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product (2D Models, 3D Bio Printing, Liver Organoids)
10.2.2. By Application (Drug Discovery, Academics & Research)
10.2.3. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Human Liver Model Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Application
10.3.2. Saudi Arabia Human Liver Model Market Outlook
